We are proud to announce the return of our 3rd annual Peptides event to London in 2016!
In recent years, therapeutic
peptides have been developed for the treatment of several diseases such as cancer, metabolic disorders, nervous system disorders and gastrointestinal disorders, among others. Further research has been done to develop a rich pipeline of novel
peptides as a result of their efficacy treating a huge array of conditions, and the global
peptide therapeutics market is expected to reach a value of US$23.7B by 2020
Our 3rd annual
Peptides event provides the perfect platform to discuss the latest innovations and development in the
peptides industry and explore a number of pressing issues such as the use of Cell Penetrating
Peptides (CPP), the challenges involved with oral
peptides and many more.
Benefits of Attending
- Hear from and meet with the key innovators in peptides research, technologies and peptide therapeutics.
- Discover collaborative solutions to peptides research and technology challenges.
- Discuss the latest innovations in peptide therapeutics, including utilising peptides in the clinic and developments in peptide drug delivery systems
Plus Two Interactive Half-Day Pre-Conference Workshops | Tuesday 5th July 2016
A: Cyclic Peptides: Discovery, Development and DeploymentWorkshop Leaders: Dan Teufel, Head of Chemistry, Bicycle Therapeutics Limited
Roger New, Co founder and CSO, Proxima Concepts Ltd
08.30 - 12.30
B: Cupid Cell Penetrating Peptides - A Powerful New Tool For Cellular ResearchWorkshop Leader: Jonathan Ryves, Director, Cupid Peptides
13.30 - 17.30
Speakers
- Aline Miller, Professor of Biomolecular Engineering, University Of Manchester
- Ashok Bhandari, VP, Chemistry, Protagonist Therapeutics
- Dan Teufel, Head of Chemsitry, Bicycle Therapeutics Limited
- Daniel Samson, Director API Manufacturing, Bachem
- Elisabetta Bianchi, Head of Peptide Chemistry , IRBM Science Park
- Evelyne Fontaine, Scientist, Sanofi-Aventis
- Gary Bembridge, Director of Scientific Affairs Immunology, Abzena
- Joanna Hay, Science Manager, Albumedix
- Jonathan Ryves, Director, Cupid Peptides
- Leila Narimen Beniddir, Study Manager/Scientist- Novel Drug Delivery Technologies, Ipsen
- Lutz Jermutus, Senior Director, R&D, MedImmune
- Mathias Schaffrath, Group Head Chromatography, Sanofi-Aventis
- Oliver Demmer, Innovation Consultant, Ministry Of Foreign Affairs
- Renata Zbozien, Senior Scientist, Haemostatix Ltd
- Roger New, Director, R&D, Proxima Concepts Ltd
- Saif Shubber, Formulation Scientist, MedImmune Inc.
- Vincent Bille, Founder & Owner, Marble Pharma Consult, sprl
Please fill in your name and email to receive the conference agenda of this event.
The agenda is available as PDF under downloads at the right side o f the page.
Venue
Holiday Inn Kensington Forum
97 Cromwell Rd, Kensington, SW7 4DN
London, UK
Who should attend
- Head of Formulation
- Head of Peptide Chemistry
- Vice President, Peptides
- Vice President, Diabetes Protein and Peptide Chemistry
- Head of small molecules
- Formulation Scientist
- Global Head of Protein Engineering
- Lab Head of Early Development
Venue
Holiday Inn Kensington Forum97 Cromwell Road
London, United Kingdom
